Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report.
Rizos
E N
EN
Chatziioannou
S
S
Siafakas
N
N
Douzenis
A
A
Katsantoni
E
E
Mandrapilia
A
A
Bacalis
S
S
Fotiadis
C
C
Lykouras
L
L
D014150:Antipsychotic Agents / Q000627:therapeutic use; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D050483:Dopamine Plasma Membrane Transport Proteins; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone